Target intelligence / Profile preview

Beta-Lactamase Ambler Class A (Class A Beta-Lactamase)

Target
Class A Beta-Lactamase
Molecular classification
Enzyme, Hydrolase, Beta-Lactamase
01

Overview

Beta-lactamase enzymes are bacterial enzymes that hydrolyze and inactivate beta-lactam antibiotics, leading to antibiotic resistance. The Ambler classification system divides beta-lactamases into four classes (A–D) based on amino acid sequence homology. Ambler class A beta-lactamases are serine-based enzymes that use a conserved serine residue (Ser70) as a nucleophile to attack the carbonyl carbon of the amide bond in the β-lactam ring of antibiotics. This reaction results in cleavage of the β-lactam ring, rendering the antibiotic ineffective. Class A enzymes can hydrolyze penicillins, most cephalosporins, monobactams, and some carbapenems. Common pathogens producing class A beta-lactamases include *Klebsiella pneumoniae*, *Escherichia coli*, and *Pseudomonas aeruginosa*. Many class A beta-lactamases are inhibited by classical inhibitors such as clavulanic acid or tazobactam.

Other names
Ambler Class A Beta-LactamaseClass A β-Lactamase
02

Mechanism of action

Hydrolyzes β-lactam ring of antibiotics, rendering them ineffective against penicillin-binding proteins (PBPs).

03

Biological functions

Hydrolysis of beta-lactam antibioticsDrug resistanceBacterial cell wall synthesis (indirectly)
04

Disease associations

Antibiotic resistanceInfectionHospital-acquired infections
05

Safety considerations

Spread of antibiotic resistanceTreatment failureEmergence of multi-drug resistant organismsInhibitor resistance
06

Interacting drugs

Penicillins

5 more in the full profile.

Beyond the preview

Go deeper on Beta-Lactamase Ambler Class A (Class A Beta-Lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-Lactamase Ambler Class A (Class A Beta-Lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call